# PubMed record PMID 42288971

> PeptideScanner retained PubMed bibliographic metadata for PMID 42288971 at 2026-08-10T10:49:10.679Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-14. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42288971-semaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-03
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42288971-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42288971-semaglutide-v1.json
- Content SHA-256: `6c71f5d5e9428348750c23facfd5b87e8e8b38d47e0ae26ee670b2a5f6daa8c2`

## Claims and source pins

### Headline

PubMed record PMID 42288971 ([`pubmed-observation-pmid-42288971-2026-08-03-020e2615e052`](#source-pubmed-observation-pmid-42288971-2026-08-03-020e2615e052))

### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42288971 at 2026-08-10T10:49:10.679Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-14. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42288971-2026-08-03-020e2615e052`](#source-pubmed-observation-pmid-42288971-2026-08-03-020e2615e052))

### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42288971 at 2026-08-10T10:49:10.679Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-14. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42288971-2026-08-03-020e2615e052`](#source-pubmed-observation-pmid-42288971-2026-08-03-020e2615e052))

### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42288971-2026-08-03-020e2615e052`](#source-pubmed-observation-pmid-42288971-2026-08-03-020e2615e052))

## Sources

<a id="source-pubmed-observation-pmid-42288971-2026-08-03-020e2615e052"></a>
- **PubMed record PMID 42288971 · retained source version 1:2026-08-03:current:020e2615e0522b5440709712ad64b69fdf94665b19313548ecfc4328dd4c7c52** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42288971/) (`pubmed-observation-pmid-42288971-2026-08-03-020e2615e052`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "PubMed record PMID 42288971." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42288971-semaglutide-v1.json SHA-256: 6c71f5d5e9428348750c23facfd5b87e8e8b38d47e0ae26ee670b2a5f6daa8c2.

